NEW YORK, April 8, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022 and August 2, 2024, both dates inclusive (the "Class Period"), of the important...
Read More Details
Finally We wish PressBee provided you with enough information of ( ATNM Investors Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit )
Also on site :
- A U-Turn and an Epic Comeback! Who Went Home on 'The Amazing Race 37' Tonight?
- Ukraine-Russia war live: Putin launches mass drone attack on Dnipro while Trump envoys head for European talks
- China says it will pay no attention to Trump’s ‘tariff numbers game’